These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 22227137)
1. The neurochemical profile quantified by in vivo 1H NMR spectroscopy. Duarte JM; Lei H; Mlynárik V; Gruetter R Neuroimage; 2012 Jun; 61(2):342-62. PubMed ID: 22227137 [TBL] [Abstract][Full Text] [Related]
2. Proton MR spectroscopy in neoplastic and non-neoplastic brain disorders. Castillo M; Kwock L; Scatliff J; Mukherji SK Magn Reson Imaging Clin N Am; 1998 Feb; 6(1):1-20. PubMed ID: 9449737 [TBL] [Abstract][Full Text] [Related]
3. In vivo 1H-[13C]-NMR spectroscopy of cerebral metabolism. de Graaf RA; Mason GF; Patel AB; Behar KL; Rothman DL NMR Biomed; 2003; 16(6-7):339-57. PubMed ID: 14679499 [TBL] [Abstract][Full Text] [Related]
4. In vivo 17O NMR approaches for brain study at high field. Zhu XH; Zhang N; Zhang Y; Zhang X; Ugurbil K; Chen W NMR Biomed; 2005 Apr; 18(2):83-103. PubMed ID: 15770611 [TBL] [Abstract][Full Text] [Related]
5. Proton MR spectroscopy of the brain. Rand SD; Prost R; Li SJ Neuroimaging Clin N Am; 1999 May; 9(2):379-95. PubMed ID: 10318721 [TBL] [Abstract][Full Text] [Related]
6. Handling macromolecule signals in the quantification of the neurochemical profile. Cudalbu C; Mlynárik V; Gruetter R J Alzheimers Dis; 2012; 31 Suppl 3():S101-15. PubMed ID: 22543852 [TBL] [Abstract][Full Text] [Related]
7. Nuclear magnetic resonance imaging. Basic principles. Tress BM; Brant-Zawadski M Med J Aust; 1985 Jan; 142(1):21-4. PubMed ID: 3880860 [TBL] [Abstract][Full Text] [Related]
8. Differences in metabolic and morphological reactions after radiation therapy: proton NMR spectroscopy and imaging of patients with intracranial tumors. Ikehira H; Miyamoto T; Yasukawa T; Obata T; Katoh H; Koga M; Yoshikawa K; Yoshida K; Tateno Y Radiat Med; 1995; 13(5):199-204. PubMed ID: 8848553 [TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of H and P MRS applications. Khan SA; Cox IJ; Hamilton G; Thomas HC; Taylor-Robinson SD Liver Int; 2005 Apr; 25(2):273-81. PubMed ID: 15780050 [TBL] [Abstract][Full Text] [Related]
15. Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders. Soares JC; Krishnan KR; Keshavan MS Depression; 1996; 4(1):14-30. PubMed ID: 9160650 [TBL] [Abstract][Full Text] [Related]
16. Quantitative in vivo neurochemical profiling in humans: where are we now? McKay J; Tkáč I Int J Epidemiol; 2016 Oct; 45(5):1339-1350. PubMed ID: 27794521 [TBL] [Abstract][Full Text] [Related]
17. Long-term normal-appearing brain tissue monitoring after irradiation using proton magnetic resonance spectroscopy in vivo: statistical analysis of a large group of patients. Matulewicz Ł; Sokół M; Michnik A; Wydmański J Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):825-32. PubMed ID: 16949766 [TBL] [Abstract][Full Text] [Related]
18. Spectroscopic findings in attention-deficit/hyperactivity disorder: review and meta-analysis. Perlov E; Philipsen A; Matthies S; Drieling T; Maier S; Bubl E; Hesslinger B; Buechert M; Henning J; Ebert D; Tebartz Van Elst L World J Biol Psychiatry; 2009; 10(4 Pt 2):355-65. PubMed ID: 18609427 [TBL] [Abstract][Full Text] [Related]
19. In vivo MR spectroscopy of human dementia. Ross BD; Bluml S; Cowan R; Danielsen E; Farrow N; Tan J Neuroimaging Clin N Am; 1998 Nov; 8(4):809-22. PubMed ID: 9769343 [TBL] [Abstract][Full Text] [Related]
20. Combined passive and active shimming for in vivo MR spectroscopy at high magnetic fields. Juchem C; Muller-Bierl B; Schick F; Logothetis NK; Pfeuffer J J Magn Reson; 2006 Dec; 183(2):278-89. PubMed ID: 17011219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]